Volume | 6,096,792 |
|
|||||
News | - | ||||||
Day High | 1.5395 | Low High |
|||||
Day Low | 1.36 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Pacific Biosciences of California Inc | PACB | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.4499 | 1.36 | 1.5395 | 1.38 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
16,653 | 6,096,792 | $ 1.45 | $ 8,811,734 | - | 1.25 - 14.55 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:08:16 | 100 | $ 1.455 | USD |
Pacific Biosciences of California Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
385.85M | 267.95M | - | 200.52M | -306.74M | -1.14 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Pacific Biosciences of C... News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PACB Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.47 | 1.67 | 1.30 | 1.47 | 11,244,145 | -0.015 | -1.02% |
1 Month | 3.83 | 3.845 | 1.25 | 2.00 | 12,782,193 | -2.38 | -62.01% |
3 Months | 6.60 | 6.83 | 1.25 | 3.69 | 9,801,673 | -5.15 | -77.95% |
6 Months | 6.74 | 10.65 | 1.25 | 5.51 | 8,241,685 | -5.29 | -78.41% |
1 Year | 10.25 | 14.55 | 1.25 | 7.31 | 6,026,551 | -8.80 | -85.80% |
3 Years | 31.36 | 36.36 | 1.25 | 9.75 | 5,068,047 | -29.91 | -95.36% |
5 Years | 7.36 | 53.69 | 1.25 | 11.40 | 4,105,273 | -5.91 | -80.23% |
Pacific Biosciences of C... Description
Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe. |